sizofiran has been researched along with Bladder Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arika, T; Asano, T; Matsuo, T; Mitani, M | 1 |
| Asakawa, M; Horii, A; Kyo, M; Maekawa, M; Yasumoto, R | 1 |
2 other study(ies) available for sizofiran and Bladder Cancer
| Article | Year |
|---|---|
[Antitumor activity of schizophyllan (SPG) against syngeneic ACI/N rat tumor, AMC-60 fibrosarcoma and BC-47 bladder cancer].
Topics: Animals; Cells, Cultured; Cytotoxicity, Immunologic; Female; Fibrosarcoma; Glycosaminoglycans; Lymphocyte Activation; Neoplasm Transplantation; Rats; Rats, Inbred ACI; Sarcoma, Experimental; Sizofiran; Urinary Bladder Neoplasms | 1984 |
Multidisciplinary treatment for bladder carcinoma--biological response modifiers and kampo medicines.
Topics: Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Combined Modality Therapy; Drugs, Chinese Herbal; Female; Humans; Immunologic Factors; Leucine; Male; Picibanil; Rats; Rats, Inbred Strains; Sizofiran; Urinary Bladder Neoplasms | 1991 |